KLRA Kailera Therapeutics, Inc.
Kailera Therapeutics, Inc. (KLRA) Institutional Ownership
What the institutions did with KLRA last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| Bain Capital Investors LLC | 26.3M | 22.6% |
| Bain Capital Life Sciences Investors, LLC | 22.6M | 19.4% |
| RTW INVESTMENTS, LP | 10.8M | 9.3% |
| CANADA PENSION PLAN INVESTMENT BOARD | 7.3M | 6.3% |
| Atlas Venture Life Science Advisors, LLC | 5.2M | 4.5% |
| FMR LLC | 4.0M | 3.4% |
| BlackRock, Inc. | 3.9M | 3.4% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.5M | 3.0% |
| CITADEL ADVISORS LLC | 3.2M | 2.8% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.2M | 2.8% |
| WELLINGTON MANAGEMENT GROUP LLP | 2.9M | 2.5% |
| Royalty Pharma Sub-Manager, LLC | 2.5M | 2.1% |
| Siren, L.L.C. | 2.2M | 1.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.7M | 1.5% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.7M | 1.4% |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | 1.0% |
| FARALLON CAPITAL MANAGEMENT LLC | 1.1M | 0.9% |
| Frazier Life Sciences Management, L.P. | 1.1M | 0.9% |
| Trails Edge Capital Partners, LP | 984.8K | 0.8% |
| UBS Group AG | 972.7K | 0.8% |
| Jupiter Topco LLC | 970.9K | 0.8% |
| AMERIPRISE FINANCIAL INC | 821.3K | 0.7% |
| Deep Track Capital, LP | 700.0K | 0.6% |
| EVENTIDE ASSET MANAGEMENT, LLC | 616.7K | 0.5% |
| Vestal Point Capital, LP | 575.0K | 0.5% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| Bain Capital Investors LLC | New | 0 | 26.3M | +26.3M |
| Bain Capital Life Sciences Investors, LLC | New | 0 | 22.6M | +22.6M |
| RTW INVESTMENTS, LP | New | 0 | 10.8M | +10.8M |
| CANADA PENSION PLAN INVESTMENT BOARD | New | 0 | 7.3M | +7.3M |
| Atlas Venture Life Science Advisors, LLC | New | 0 | 5.2M | +5.2M |
| FMR LLC | New | 0 | 4.0M | +4.0M |
| BlackRock, Inc. | New | 0 | 3.9M | +3.9M |
| PRICE T ROWE ASSOCIATES INC /MD/ | New | 0 | 3.5M | +3.5M |
| CITADEL ADVISORS LLC | New | 0 | 3.2M | +3.2M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | New | 0 | 3.2M | +3.2M |
| WELLINGTON MANAGEMENT GROUP LLP | New | 0 | 2.9M | +2.9M |
| Royalty Pharma Sub-Manager, LLC | New | 0 | 2.5M | +2.5M |
| Siren, L.L.C. | New | 0 | 2.2M | +2.2M |
| VANGUARD CAPITAL MANAGEMENT LLC | New | 0 | 1.7M | +1.7M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New | 0 | 1.7M | +1.7M |
| GEODE CAPITAL MANAGEMENT, LLC | New | 0 | 1.1M | +1.1M |
| FARALLON CAPITAL MANAGEMENT LLC | New | 0 | 1.1M | +1.1M |
| Frazier Life Sciences Management, L.P. | New | 0 | 1.1M | +1.1M |
| Trails Edge Capital Partners, LP | New | 0 | 984.8K | +984.8K |
| UBS Group AG | New | 0 | 972.7K | +972.7K |
| AMERIPRISE FINANCIAL INC | New | 0 | 821.3K | +821.3K |
| Deep Track Capital, LP | New | 0 | 700.0K | +700.0K |
| EVENTIDE ASSET MANAGEMENT, LLC | New | 0 | 616.7K | +616.7K |
| Vestal Point Capital, LP | New | 0 | 575.0K | +575.0K |
| Cormorant Asset Management, LP | New | 0 | 550.0K | +550.0K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.